572 related articles for article (PubMed ID: 25498210)
1. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
Altenburg AF; Rimmelzwaan GF; de Vries RD
Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
[TBL] [Abstract][Full Text] [Related]
2. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
[TBL] [Abstract][Full Text] [Related]
3. Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines.
Hillaire ML; Osterhaus AD; Rimmelzwaan GF
J Biomed Biotechnol; 2011; 2011():939860. PubMed ID: 22007149
[TBL] [Abstract][Full Text] [Related]
4. A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.
Lee YN; Lee YT; Kim MC; Gewirtz AT; Kang SM
J Immunol; 2016 Mar; 196(6):2637-45. PubMed ID: 26864033
[TBL] [Abstract][Full Text] [Related]
5. Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination.
Jansen JM; Gerlach T; Elbahesh H; Rimmelzwaan GF; Saletti G
J Clin Virol; 2019 Oct; 119():44-52. PubMed ID: 31491709
[TBL] [Abstract][Full Text] [Related]
6. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
[TBL] [Abstract][Full Text] [Related]
7. Epitope specific T-cell responses against influenza A in a healthy population.
Savic M; Dembinski JL; Kim Y; Tunheim G; Cox RJ; Oftung F; Peters B; Mjaaland S
Immunology; 2016 Feb; 147(2):165-77. PubMed ID: 26489873
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to influenza virus infection.
Kreijtz JH; Fouchier RA; Rimmelzwaan GF
Virus Res; 2011 Dec; 162(1-2):19-30. PubMed ID: 21963677
[TBL] [Abstract][Full Text] [Related]
9. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus.
Richards KA; Topham D; Chaves FA; Sant AJ
J Immunol; 2010 Nov; 185(9):4998-5002. PubMed ID: 20889549
[TBL] [Abstract][Full Text] [Related]
11. Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge.
Magini D; Giovani C; Mangiavacchi S; Maccari S; Cecchi R; Ulmer JB; De Gregorio E; Geall AJ; Brazzoli M; Bertholet S
PLoS One; 2016; 11(8):e0161193. PubMed ID: 27525409
[TBL] [Abstract][Full Text] [Related]
12. Keeping the memory of influenza viruses.
Combadière B; Sibéril S; Duffy D
Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
[TBL] [Abstract][Full Text] [Related]
13. Protein Vaccination Directs the CD4
Rattan A; Richards KA; Knowlden ZAG; Sant AJ
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341045
[TBL] [Abstract][Full Text] [Related]
14. A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice.
Di Mario G; Garulli B; Sciaraffia E; Facchini M; Donatelli I; Castrucci MR
Virol J; 2016 Mar; 13():56. PubMed ID: 27036323
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.
Bodewes R; Kreijtz JH; Hillaire ML; Geelhoed-Mieras MM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Gen Virol; 2010 Jul; 91(Pt 7):1743-53. PubMed ID: 20335492
[TBL] [Abstract][Full Text] [Related]
16. A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.
Matsui M; Kohyama S; Suda T; Yokoyama S; Mori M; Kobayashi A; Taneichi M; Uchida T
Biochem Biophys Res Commun; 2010 Jan; 391(3):1494-9. PubMed ID: 20060099
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.
Di Mario G; Sciaraffia E; Facchini M; Gubinelli F; Soprana E; Panigada M; Bernasconi V; Garulli B; Siccardi A; Donatelli I; Castrucci MR
Pathog Glob Health; 2017 Mar; 111(2):76-82. PubMed ID: 28079473
[TBL] [Abstract][Full Text] [Related]
18. Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations.
Liu J; Wu B; Zhang S; Tan S; Sun Y; Chen Z; Qin Y; Sun M; Shi G; Wu Y; Sun M; Liu N; Ning K; Ma Y; Gao B; Yan J; Zhu F; Wang H; Gao GF
Eur J Immunol; 2013 Aug; 43(8):2055-69. PubMed ID: 23681926
[TBL] [Abstract][Full Text] [Related]
19. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein gp96 adjuvant induces T cell responses and cross-protection to a split influenza vaccine.
Ju Y; Fan H; Liu J; Hu J; Li X; Li C; Chen L; Gao Q; Gao GF; Meng S
Vaccine; 2014 May; 32(23):2703-11. PubMed ID: 24699472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
